Results 81 to 90 of about 20,811 (229)

Comparison of Effectiveness Using Different Dual Bronchodilator Agents in Chronic Obstructive Pulmonary Disease Treatment. [PDF]

J Clin Med, 2021
Cheng SL.
europepmc   +1 more source

Common respiratory diseases. [PDF]

, 2010
The self-medication phenomenon in upper respiratory tract infections, rhinosinusitis, asthma, and chronic obstructive pulmonary disease are significant and will continue to increase.
Kilgore, David, Najm, Wadie
core  

Regional ventilation changes in the lung: Treatment response mapping by using hyperpolarized gas MR imaging as a quantitative biomarker [PDF]

, 2017
Purpose: To assess the magnitude of regional response to respiratory therapeutics in the lungs using Treatment Response Mapping (TRM) with hyperpolarized gas MRI.
Brightling, C.E., Collier, G.J., Horn, F.C., Kay, R., Marshall, H., Parra-Robles, J., Siddiqui, S., Wild, J.M.   +7 more
core   +1 more source

Structure and functional impact of seed region variant in MIR-499 gene family in bronchial asthma

Respiratory Research, 2017
Background Small non-coding RNAs (microRNAs) have been evolved to master numerous cellular processes. Genetic variants within microRNA seed region might influence microRNA biogenesis and function.
Eman A. Toraih, Mohammad H. Hussein, Essam Al Ageeli, Eman Riad, Nouran B. AbdAllah, Ghada M. Helal, Manal S. Fawzy   +6 more
doaj   +1 more source

Current GOLD recommendations and its implementation within hospitalised COPD patients in Malta [PDF]

, 2015
In 2012, Global Initiative for Chronic Obstructive Lung Disease (GOLD) revised their classification of Chronic Obstructive Pulmonary Disease patients, incorporating spirometry, symptoms and recent exacerbations.
Bilocca, David, Gauci, Jonathan, Mifsud, Maria, Montefort, Stephen, Yamagata, Kentaro   +4 more
core  

Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. [PDF]

, 2015
Medication adherence among patients with chronic diseases, such as COPD, may be suboptimal, and many factors contribute to this poor adherence. One major factor is the frequency of medication dosing.
Albertson, Timothy E, Harper, Richart, Murin, Susan, Sandrock, Christian   +3 more
core   +1 more source

Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study

Pulmonary Therapy, 2019
Introduction To address the burden of chronic obstructive pulmonary disease (COPD), the Global Initiative for Chronic Obstructive Lung Disease (GOLD) recommends treatment according to classification of patients by symptom severity and exacerbation risk ...
Riju Ray, Beth Hahn, Richard H. Stanford, John White, Breanna Essoi, Alyssa Goolsby Hunter   +5 more
doaj   +1 more source

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. [PDF]

, 2019
ObjectiveBronchodilator responsiveness (BDR) is prevalent in COPD, but its clinical implications remain unclear. We explored the significance of BDR, defined by post-bronchodilator change in FEV1 (BDRFEV1) as a measure reflecting the change in flow and ...
Anderson, Wayne, Arjomandi, Mehrdad, Barjaktarevic, Igor Z, Bhakta, Nirav R, Bhatt, Surya P, Bowler, Russell, Buhr, Russell G, Christenson, Stephanie A, Cooper, Christopher B, Couper, David, Criner, Gerard, Curtis, Jeffrey L, Doerschuk, Claire M, Dransfield, Mark T, Drummond, M Bradley, Han, MeiLan K, Hansel, Nadia, Hoffman, Eric A, Hu, Scott, Kaner, Robert J, Kanner, Richard E, Kim, Victor, Krishnan, Jerry A, Martinez, Fernando J, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS), O'Neal, Wanda K, Ortega, Victor E, Paine Iii, Robert, Peters, Stephen P, Pirozzi, Cheryl S, Ronish, Bonnie, Tashkin, Donald P, Wang, Xiaoyan, Wells, James Michael, Woodruff, Prescott G   +34 more
core   +2 more sources

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients

International Journal of COPD, 2020
José Luis López-Campos,1,2 Bernardino Alcázar Navarrete,3 Juan Antonio Riesco Miranda,2,4 Borja G Cosío,2,5 Juan P de-Torres,6 Bartolomé Celli,7 Carlos A Jiménez-Ruiz,8 Ciro Casanova Macario9 1Unidad Mé ...
López-Campos JL, Alcázar Navarrete B, Riesco Miranda JA, Cosío BG, de-Torres JP, Celli B, Jiménez-Ruiz CA, Casanova Macario C   +7 more
doaj  

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD

Pulmonary Therapy, 2019
Inhaled fixed-dose combinations (FDCs) of a long-acting β-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) have become the cornerstone for the maintenance treatment of symptomatic COPD patients.
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi, David Price   +5 more
doaj   +1 more source